Characteristics

All

(N = 39)

Response

p-value

No response (N = 19)

OAR (N = 20)

No.

(%)

No.

(%)

No.

(%)

Age (years)

Mean ± SD

57.79

±12.01

56.57

±11.45

58.95

±12.71

0.473•

Median (Range)

54

(39 - 74)

54

(42 - 74)

59

(39 - 74)

≤60 years

20

(51.3%)

10

(50%)

10

(50%)

0.869§

>60 years

19

(48.7%)

9

(47.4%)

10

(52.6%)

Sex

Male

23

(59%)

10

(43.5%)

13

(56.5%)

0.433§

Female

16

(41%)

9

(56.3%)

7

(43.8%)

Rai classification

Stages 0, 1 & 2

16

(41%)

3

(18.8%)

13

(81.3%)

0.002§

Stages 3 & 4

23

(59%)

16

(69.6%)

7

(30.4%)

Hepatomegally

Absent

21

(53.8%)

11

(52.4%)

10

(47.6%)

0.621§

Present

18

(46.2%)

8

(44.4%)

10

(55.6%)

Lymphadenopathy

Absent

13

(33.3%)

5

(38.5%)

8

(61.5%)

0.365§

Present

26

(66.6%)

14

(53.8%)

12

(46.2%)

Spleenomegally

Absent

9

(23.1%)

1

(11.1%)

8

(88.9%)

0.020§

Present

30

(76.9%)

18

(60%)

12

(40%)

WBCs (×10³/mm³)

Mean ± SD

49.44

±33.21

47.46

±23.50

51.32

±40.93

0.407•

Median (Range)

36

(17.50 - 122.80)

43

(17.50 - 112.50)

32.35

(17.50 - 122.80)

<100 × 10³/mm³

33

(84.6%)

18

(54.5%)

15

(45.5%)

0.182§

≥100 × 10³/mm³

6

(15.4%)

1

(16.7%)

5

(83.3%)

Absolute lymphocytes (×10³/mm³)

Mean ± SD

27.72

±17.09

26.61

±15.29

28.79

±18.97

0.855•

Median (Range)

19.30

(9.10 - 67)

19

(13 - 67)

21.15

(9.10 - 67)

<30 × 10³/mm³

27

(69.2%)

13

(48.1%)

14

(51.9%)

0.915§

≥30 × 10³/mm³

12

(30.8%)

6

(50%)

6

(50%)

Platelet count (×10³/mm³)

Mean ± SD

121.61

±48.49

97.68

±33.79

144.35

±50.05

0.004•

Median (Range)

112

(45 - 205)

89

(49 - 180)

159.50

(45 - 205)